debrisoquin has been researched along with moclobemide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Blouin, RA; Guentert, TW; Pfefen, JP; Schoerlin, MP | 1 |
| Brøsen, K; Gram, LF | 1 |
1 trial(s) available for debrisoquin and moclobemide
| Article | Year |
|---|---|
Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group.
Topics: Adult; Aged; Benzamides; Cimetidine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Female; Humans; Male; Middle Aged; Mixed Function Oxygenases; Moclobemide; Monoamine Oxidase Inhibitors; Morpholines; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Single-Blind Method; Sparteine | 1993 |
2 other study(ies) available for debrisoquin and moclobemide
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Comparison of the pharmacokinetics of moclobemide in poor and efficient metabolizers of debrisoquine.
Topics: Adult; Aged; Antidepressive Agents; Benzamides; Biological Availability; Debrisoquin; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Phenotype | 1990 |